• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Avatrombopag Maleate
BioHub® Magnetic Separator
Avatrombopag
Ursodeoxycholic acid
Troxerutin
CytoLinX® BRTF Single-use Top-driven Bioreactor Bag

Granules gets US FDA nod for OTC naproxen sodium and diphenhydramine hydrochloride tablets

expresspharmaSeptember 27, 2020

Tag: granules india , FDA , naproxen sodium , diphenhydramine hydrochloride tablets

Granules India announced that the US Food & Drug Administration (US FDA) has approved its abbreviated new drug application (ANDA) for naproxen sodium and diphenhydramine hydrochloride tablets, 220 mg/25 mg (OTC), generic equivalent of Aleve PM Tablets, 220 mg/25 mg, of Bayer HealthCare.

Naproxen sodium and diphenhydramine hydrochloride tablets are used for relief of occasional sleeplessness associated with minor aches and pains and to help you fall asleep and stay asleep.

Granules now has a total of 31 ANDA approvals from US FDA (29 final approvals and two tentative approvals).

Previous:Dr Reddy’s launches dexmedetomidine hydrochloride in 0.9% sodium chloride injection in US

Next:US FDA approves Zydus Cadila’s dimethyl fumarate DR capsules

Related News

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

PharmaSourcesNovember 22, 2024

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, today opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts.

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Biotech NewswireNovember 20, 2024

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

PR NEWSWIRENovember 20, 2024

Granules gets US FDA nod for OTC naproxen sodium and diphenhydramine hydrochloride tablets | Pharmasources.com

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Discover how AI in pharmacovigilance improves drug safety by predicting risks, identifying harmful interactions, and enhancing patient outcomes.

You may like
More>>

Deoxycyline (FDA)

Deoxycyline (FDA)
Hexafluorodianhydride(6-FDA)

Hexafluorodianhydride(6-FDA)
Naproxen sodium

Naproxen sodium
Tacrolimus (FDA)

Tacrolimus (FDA)
Mitomycin ( FDA)

Mitomycin ( FDA)
Tobramycin base( FDA)

Tobramycin base( FDA)
Lincomycin HCL (FDA)

Lincomycin HCL (FDA)
Bumetanide (FDA)

Bumetanide (FDA)
Naproxen/ Sodium salt (FDA/COS)

Naproxen/ Sodium salt (FDA/COS)
Naproxen sodium

Naproxen sodium

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service